ISORDIL Drug Patent Profile
✉ Email this page to a colleague
When do Isordil patents expire, and when can generic versions of Isordil launch?
Isordil is a drug marketed by Wyeth Ayerst, Bausch, and Biovail. and is included in three NDAs.
The generic ingredient in ISORDIL is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isordil
A generic version of ISORDIL was approved as isosorbide dinitrate by PH HEALTH on March 12th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ISORDIL?
- What are the global sales for ISORDIL?
- What is Average Wholesale Price for ISORDIL?
Summary for ISORDIL
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 6 |
| Patent Applications: | 4,208 |
| Drug Prices: | Drug price information for ISORDIL |
| What excipients (inactive ingredients) are in ISORDIL? | ISORDIL excipients list |
| DailyMed Link: | ISORDIL at DailyMed |
Recent Clinical Trials for ISORDIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Brigham and Women's Hospital | Phase 4 |
| University of Cape Town | Phase 3 |
Pharmacology for ISORDIL
| Drug Class | Nitrate Vasodilator |
| Physiological Effect | Vasodilation |
US Patents and Regulatory Information for ISORDIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | ISORDIL | isosorbide dinitrate | CAPSULE, EXTENDED RELEASE;ORAL | 012882-002 | Jul 29, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bausch | ISORDIL | isosorbide dinitrate | TABLET;ORAL | 012093-001 | Jul 29, 1988 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Bausch | ISORDIL | isosorbide dinitrate | TABLET;ORAL | 012093-002 | Jul 29, 1988 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biovail | ISORDIL | isosorbide dinitrate | TABLET;SUBLINGUAL | 012940-004 | Jul 29, 1988 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wyeth Ayerst | ISORDIL | isosorbide dinitrate | TABLET, EXTENDED RELEASE;ORAL | 012882-001 | Jul 29, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
